These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17553552

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A, Mikkelsson J, Reséndiz JC, Viiri L, Backman JT, Kankuri E, Karhunen PJ, Lassila R.
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [Abstract] [Full Text] [Related]

  • 47. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Prevalence of aspirin resistance in patients with type 2 diabetes.
    Fateh-Moghadam S, Plöckinger U, Cabeza N, Htun P, Reuter T, Ersel S, Gawaz M, Dietz R, Bocksch W.
    Acta Diabetol; 2005 Jun; 42(2):99-103. PubMed ID: 15944844
    [Abstract] [Full Text] [Related]

  • 50. Point of care testing of aspirin resistance in patients with vascular disease.
    Wong S, Ward CM, Appleberg M, Lewis DR.
    ANZ J Surg; 2006 Oct; 76(10):873-7. PubMed ID: 17007614
    [Abstract] [Full Text] [Related]

  • 51. Impact of genetic polymorphisms on platelet function and aspirin resistance.
    Pamukcu B, Oflaz H, Onur I, Hancer V, Yavuz S, Nisanci Y.
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):53-6. PubMed ID: 19923980
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE, Mantzios G, Giannopoulou V, Tsirigotis P, Bonovas S, Rapti E, Mygiaki E, Kartasis Z, Sitaras NM, Dervenoulas J, Travlou A.
    Thromb Res; 2008 Jan; 123(1):100-7. PubMed ID: 18430462
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M, Janicki PK, Rosiak M, Przybylkowski A, Kaplon-Cieslicka A, Grygorowicz T, Trzepla E, Filipiak KJ, Czlonkowski A, Opolski G.
    Cardiol J; 2013 Jan; 20(2):170-7. PubMed ID: 23558875
    [Abstract] [Full Text] [Related]

  • 58. Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin.
    De Caterina R, Sicari R, Bernini W, Lazzerini G, Buti Strata G, Giannessi D.
    Thromb Haemost; 1991 May 06; 65(5):504-10. PubMed ID: 1871711
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.